Beta 1.1. Audio news feature is available for Chrome 33+ and Safari 7+ browsers.
Chinese Drugmaker’s IPO Tests a Slumping Biotech Market - WSJ
A Chinese cancer drug developer is pushing ahead with an initial public offering in Hong Kong, despite a global markets rout and the recent poor performance of other biotechnology startups that have listed in the city.
In China, a Dot-Com Déjà-Vu - WSJ
We’ve seen it before: the crazy spending, the stratospheric valuations. Twenty years later, it looks like the dot-com boom all over again, but this time the players are much bigger—and Chinese.
U.S. Edges Toward New Cold-War Era With China
WASHINGTON—The Trump administration is moving deliberately to counter what the White House views as years of unbridled Chinese aggression, taking aim at military, political and economic targets in Beijing and signaling a new and potentially much colder era in U.S.-China relations.